Severe thrombocytopenia after hepatitis B vaccine in an infant from Turkey.
Recombinant hepatitis B vaccine has been used widely in the world since 1991. The side effects of hepatitis B vaccine are seen rarely. In this paper, we present clinical and laboratory progress of an infant who gets severe thrombocytopenia after the second dosage hepatitis B vaccine. Our case is different from other cases because our patient is very young, the number of platelet is the lowest in the literature, and intravenous immunoglobulin (IVIG) are immunoglobulin (IVIG) are used in the treatment. Although it is a severe thrombocytopenia, the patient has recovered without any bleeding.
Polat
Aziz
A
Fatih University, Faculty of Medicine, Department of Pediatric Hematology, Hoşdere Caddesi No: 145, 06540 Y. Ayranci, Ankara, Turkey. azizp4@yahoo.com.tr
Akca
Halise
H
Dagdeviren
Erol
E
D005260:Female; D017325:Hepatitis B Vaccines / Q000009:adverse effects*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D010976:Platelet Count; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy; D014421:Turkey
D017325:Hepatitis B Vaccines; D016756:Immunoglobulins, Intravenous